Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west
- 1 September 2019
- journal article
- review article
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 4 (9) , 721-730
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJournal of Hepatology, 2012
- Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombusCancer Biology & Therapy, 2011
- Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review)Oncology Letters, 2011
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative StudyAnnals of Surgical Oncology, 2010
- Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor ThrombusAnnals of Surgical Oncology, 2010
- Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatmentWorld Journal of Gastroenterology, 2010
- Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survivalHPB, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter studySurgery, 2005
- A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patientsHepatology, 1998